NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/07/2025
Voltar para busca
Dado oficial do USPTO
1 EUEAL BIOTECH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
58
Atualização mais recente
29/07/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
27/05/2022
Data de registro
29/07/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/07/2025
Última transação
29/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2023-00-00
Primeiro uso no comércio
2023-00-00
Código do desenho
5
Tipo de titular
03
Localização do titular
Chungcheongbuk-do, KR
Examinador
SALES, HEATHER ALISON
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "EUEAL" in bold font, followed by the wording "BIOTECH" below. To the left of these wordings is a design that looks like a large stylized number "1".
Titulares e representantes
Titulares
N-CELL CO., LTD.
Representantes
SANG HO LEE BRIDGEWAY IP LAW GROUP, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Nutraceutical preparations for therapeutic and medical purposes for prevention and treatment of cancercardiovascular diseaseshypertensionatherosclerosisischemiaaneurysmsictusinfarctionanginastrokecerebrovascular accidentsneurodegenerative diseasesAlzheimer's diseaseParkinson's diseasemultiple sclerosisamyotrophic lateral sclerosis (ALS)sclerosis of the hippocampusepilepsyfocal sclerosisadrenoleukodystrophyleukodystrophyvascular dementiasenile dementiaheadachesmigraine headachescentral nervous system traumasleep disordersdizzinesspaindepressionanxietydrug and alcohol addictionsblindnesshearing problemsdisorientationaltered moodobesityoverweightnessmetabolic disordershypercholesterolemiahypertriglyceridemiahyperglycaemiadiabetesinflammatory diseasesinfectious diseasesautoimmune diseases; pharmaceutical preparations for the prevention of diseases in the immune system; health food supplements; crude medicinesmedicines for treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; dietary supplemental nutritive substances being dietary supplements; nutraceuticals for use as a dietary supplement; dietetic preparations adapted for medical purposesdietetic food supplements; dietary and nutritionally fortified food being dietetic foods adapted for medical purposes; food supplements for medical purposes; nutritionally fortified beverages for medical purposes; none of the foregoing containing ingredients from the cannabis sativa L plant or its extracts
Publicações
Histórico de despachos e eventos da marca no USPTO.
58 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
29/07/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16/07/2025
EXPT
EXPARTE APPEAL TERMINATED
05/07/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/07/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
01/07/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/07/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
01/07/2025
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
01/07/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
10/06/2025
EXPI
EX PARTE APPEAL-INSTITUTED
04/04/2025
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
04/04/2025
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
18/01/2025
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
18/01/2025
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
18/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/01/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/01/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/01/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/10/2024
GNFR
FINAL REFUSAL E-MAILED
04/10/2024
CNFR
SU - FINAL REFUSAL - WRITTEN
04/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/09/2024
ALIE
ASSIGNED TO LIE
29/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/03/2024
GNRT
NON-FINAL ACTION E-MAILED
02/03/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
02/03/2024
DOCK
ASSIGNED TO EXAMINER
28/02/2024
DOCK
ASSIGNED TO EXAMINER
26/02/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
21/02/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
21/02/2024
IUAF
USE AMENDMENT FILED
30/01/2024
EISU
TEAS STATEMENT OF USE RECEIVED
30/01/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/08/2023
PUBO
PUBLISHED FOR OPPOSITION
08/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/07/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
26/06/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
26/06/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
26/06/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
26/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/06/2023
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
21/03/2023
GPRA
PRIORITY ACTION E-MAILED
21/03/2023
CPRA
PRIORITY ACTION WRITTEN
21/03/2023
DOCK
ASSIGNED TO EXAMINER
15/03/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/10/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/10/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/06/2022
NWAP
NEW APPLICATION ENTERED
31/05/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace 1 EUEAL BIOTECH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.